These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19890641)

  • 1. Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging.
    Barber TM; Alvey C; Greenslade T; Gooding M; Barber D; Smith R; Marland A; Wass JA; Child T; McCarthy MI; Franks S; Golding SJ
    Eur Radiol; 2010 May; 20(5):1207-13. PubMed ID: 19890641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of magnetic resonance imaging and ultrasonography for diagnosis of polycystic ovary syndrome in adolescent girls.
    Kenigsberg LE; Agarwal C; Sin S; Shifteh K; Isasi CR; Crespi R; Ivanova J; Coupey SM; Heptulla RA; Arens R
    Fertil Steril; 2015 Nov; 104(5):1302-9.e1-4. PubMed ID: 26354095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.
    Alsamarai S; Adams JM; Murphy MK; Post MD; Hayden DL; Hall JE; Welt CK
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4961-70. PubMed ID: 19846740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraindividual right-left comparison of sonographic features in polycystic ovary syndrome (PCOS) diagnosis.
    Köninger A; Koch L; Edimiris P; Nießen S; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():124-9. PubMed ID: 25150949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
    Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
    Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
    Dewailly D; Lujan ME; Carmina E; Cedars MI; Laven J; Norman RJ; Escobar-Morreale HF
    Hum Reprod Update; 2014; 20(3):334-52. PubMed ID: 24345633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age-matched controls.
    Brown M; Park AS; Shayya RF; Wolfson T; Su HI; Chang RJ
    J Magn Reson Imaging; 2013 Sep; 38(3):689-93. PubMed ID: 23292744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transvaginal ultrasonographic morphology in polycystic ovarian syndrome.
    Takahashi K; Okada M; Ozaki T; Uchida A; Yamasaki H; Kitao M
    Gynecol Obstet Invest; 1995; 39(3):201-6. PubMed ID: 7789918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
    Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian volume and follicle number in the diagnosis of polycystic ovary syndrome in Chinese women.
    Chen Y; Li L; Chen X; Zhang Q; Wang W; Li Y; Yang D
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):700-3. PubMed ID: 18773451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis.
    Christ JP; Gunning MN; Fauser BCJM
    Reprod Biomed Online; 2017 Oct; 35(4):480-483. PubMed ID: 28733169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.